Cite
Spaan M, van den Belt-Dusebout AW, Lambalk CB, et al. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology. J Natl Cancer Inst. 2021;113(6):699-709doi: 10.1093/jnci/djaa163.
Spaan, M., van den Belt-Dusebout, A. W., Lambalk, C. B., van Boven, H. H., Schats, R., Kortman, M., Broekmans, F. J. M., Laven, J. S. E., van Santbrink, E. J. P., Braat, D. D. M., van der Westerlaken, L. A. J., Cohlen, B. J., Cantineau, A. E. P., Smeenk, J. M. J., van Rumste, M. M., Goddijn, M., van Golde, R. J. T., Meeuwissen, P. A. M., Hamilton, C. J. C. M., Ouwens, G. M., Gerritsma, M. A., Schaapveld, M., Burger, C. W., & van Leeuwen, F. E. (2021). Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology. Journal of the National Cancer Institute, 113(6), 699-709. https://doi.org/10.1093/jnci/djaa163
Spaan, Mandy, et al. "Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology." Journal of the National Cancer Institute vol. 113,6 (2021): 699-709. doi: https://doi.org/10.1093/jnci/djaa163
Spaan M, van den Belt-Dusebout AW, Lambalk CB, van Boven HH, Schats R, Kortman M, Broekmans FJM, Laven JSE, van Santbrink EJP, Braat DDM, van der Westerlaken LAJ, Cohlen BJ, Cantineau AEP, Smeenk JMJ, van Rumste MM, Goddijn M, van Golde RJT, Meeuwissen PAM, Hamilton CJCM, Ouwens GM, Gerritsma MA, Schaapveld M, Burger CW, van Leeuwen FE. Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology. J Natl Cancer Inst. 2021 Jun 01;113(6):699-709. doi: 10.1093/jnci/djaa163. PMID: 33769500; PMCID: PMC8168156.
Copy
Download .nbib